Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Expression and significance of B7-H4 and HBx in HBV related hepatocellular carcinoma

Date

19 Dec 2015

Session

Poster presentation 1

Presenters

Yun Qian

Citation

Annals of Oncology (2015) 26 (suppl_9): 42-70. 10.1093/annonc/mdv523

Authors

Y. Qian1, B. Hong2, Z. Tao1, H. Yao3

Author affiliations

  • 1 Clinical Laboratory, 2nd Affiliated Hospital of Zhejiang University University School of Medicine, 310009 - Hangzhou/CN
  • 2 Department Of Pathology, 2nd Affiliated Hospital of Zhejiang University University School of Medicine, 310009 - Hangzhou/CN
  • 3 State Key Laboratory For Diagnosis And Treatment Of Infectious Diseases, Institute Of Infectious Diseases, 1st Affiliated Hospital of Zhejiang University School of Medicine, 310003 - Hangzhou/CN
More

Resources

Abstract 409

Aim/Background

Hepatitis B virus (HBV) is a major public health problem, and Hepatitis B virus-related hepatocelular carcinoma (HBV-HCC) has an extremely poor prognosis due to a lack of effective treatments. B7-H4 is a novel member of the B7 superfamily that are actively involved in regulating the pathogenesis of tumors. However, the intrahepatic expression of B7-H4 in HBV-HCC patients has not been described. In this study, we investigated the expression and clinical significance of B7-H4 and Hepatitis B Virus X (HBx) protein in HBV-HCC.

Methods

The expression of B7-H4 in the human HCC cell lines HepG2 and HepG2215 was detected by western blotting, flow cytometry and immunofluorescence analysis. The expression of B7-H4 and HBx in 83 HBV-HCC was detected by immunohistochemistry, and the relationship with clinicopathological features was analyzed.

Results

B7-H4 was significantly up regulated in HepG2215 cells than in HepG2 cells. The positive rates of B7-H4 and HBx in 83 HBV-HCC tissues were 68.67%(57/83)and 59.04%(49/83) respectively. The expression of HBx was correlated with TNM staging. The expression of B7-H4 was positive correlated with HBx (rs = 0.388, P < 0.01). The expression level of B7-H4 in HBx-positive HBV-HCC tissues was substantially higher than that in HBx-negative HBV-HCC tissues, which was negative related to tumor TNM stage.

Conclusions

The higher expression of HBx and B7-H4 were correlated with tumor progression of HBV related hepatocelular carcinoma. B7-H4 may be an effect molecule in HBV related hepatocarcinogenesis.

Clinical trial identification

Disclosure

All authors have declared no conflicts of interest.

Resources from the same session

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings